Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer - sprookjes - yvandenbroek - TriplyDB

Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer

Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer

http://www.wikidata.org/entity/Q26995304

about

Silibinin and colorectal cancer chemoprevention: a comprehensive review on mechanisms and efficacy Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives Nutrition, dietary interventions and prostate cancer: the latest evidence Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer.Silibinin attenuates methotrexate-induced pulmonary injury by targeting oxidative stress.A Perspective on Prostate Carcinogenesis and Chemoprevention Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling Deregulation of miR-21 and miR-155 and their putative targets after silibinin treatment in T47D breast cancer cells Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth Corneal toxicity induced by vesicating agents and effective treatment options.The strategies to control prostate cancer by chemoprevention approaches.HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status.A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma.Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy.Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma.Silibinin combination with arsenic strongly inhibits survival and invasiveness of human prostate carcinoma cells.Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.Silibinin Effect on Fas/FasL, HMGB1, and CD45 Expressions in a Rat Model Subjected to Liver Ischemia-Reperfusion Injury.Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models.Increased Loading, Efficacy and Sustained Release of Silibinin, a Poorly Soluble Drug Using Hydrophobically-Modified Chitosan Nanoparticles for Enhanced Delivery of Anticancer Drug Delivery Systems.Phytochemical based nanomedicines against cancer: current status and future prospects.Effect of Silibinin on Maspin and ERα Gene Expression in MCF-7 Human Breast Cancer Cell Line.Silibinin sensitizes TRAIL-mediated apoptosis by upregulating DR5 through ROS-induced endoplasmic reticulum stress-Ca2+-CaMKII-Sp1 pathway.

P2860

Q26740421-60A9BD6D-568B-42C0-8160-F584723D14FC Q26770933-D9C6D50E-4CF9-495E-BDE1-2F121CDF4498 Q28084566-02577B5C-0B1D-4C61-AB67-FF25B5F54FE4 Q35749993-EF9D7A4C-47BE-4FB2-B344-D9743CF09113 Q35870446-618C5061-6016-47C4-A943-44172EE699E4 Q36116269-EBE99914-1695-4795-8CCA-9B12836EA4C4 Q36359585-9AFFA5BF-4004-42C2-A540-437BF35D5EE6 Q36553118-6B4759D7-8CCC-4DFD-9D53-E246133E4C1A Q36562311-A665C465-49AB-4DA0-982C-EDE61DD5C0D0 Q37083462-5359BED0-ED0F-49FD-9CB9-539F18FA4CD3 Q38175776-0B664941-31DD-44CD-B222-51808F071AD6 Q38639870-2C3789D5-B3BC-41F6-8C71-5DB9A09259E7 Q38700449-EBF13AEE-CF69-46C1-BDE3-D48A6EE22CDB Q38715263-E820EF67-1B29-46E1-B3BC-58F0DF7C1309 Q38723294-70B60235-B758-4F68-8009-94DA369740B7 Q38724100-2DD38C4F-99D0-4BB6-BC08-9378071CC499 Q38858006-07402E4C-6A20-4B07-8255-230D4E1EE261 Q38887919-EF9E5F0F-F70D-4D89-817B-7B2D04F6654E Q38949811-EBDB8A42-11C9-40F3-9668-FB7A5AE556D6 Q42693501-D60808FA-3FB4-4A8F-95B5-EDBF686FC3BE Q46241318-FF562F50-97FF-4143-A864-F9BB227F3433 Q47133287-DC9024A2-3910-4648-AAA5-D3FC0B394023 Q47829215-D5CCF3DA-212F-40ED-ABDD-C0F93149B6DE Q51743221-175086E0-1E96-493F-BC2B-B64FA34BDCA5 Q53079276-2C13ABF7-9F0A-464B-95B8-6A9E91EEAF7C

P2860

Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer

http://www.wikidata.org/entity/Q26995304

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Molecular mechanisms of silibi ...... or emphasis on prostate cancer

@ast

Molecular mechanisms of silibi ...... or emphasis on prostate cancer

@en

Molecular mechanisms of silibi ...... or emphasis on prostate cancer

@nl

type

label

Molecular mechanisms of silibi ...... or emphasis on prostate cancer

@ast

Molecular mechanisms of silibi ...... or emphasis on prostate cancer

@en

Molecular mechanisms of silibi ...... or emphasis on prostate cancer

@nl

prefLabel

Molecular mechanisms of silibi ...... or emphasis on prostate cancer

@ast

Molecular mechanisms of silibi ...... or emphasis on prostate cancer

@en

Molecular mechanisms of silibi ...... or emphasis on prostate cancer

@nl

P1433

Q26995304-0D724595-6048-48D5-9A64-21811E262C0C

P1476

Q26995304-D669A524-CF37-40AC-84C0-96BFF2B2855A

P2093

Q26995304-2F7C4EF1-B15F-4F74-B4E1-75AA13ECF93B

Q26995304-5C2F946B-896F-472E-9C32-2400ABAD6AEF

Q26995304-67AF5488-6D49-4AD7-BD88-82F20832D263

P2860

Q26995304-08124F4F-4447-40F3-B364-5D9639AD40C7

Q26995304-096317B5-03AF-431D-B95A-3D00285718D8

Q26995304-09BC49A0-DA20-4E81-A414-32A3D661011A

Q26995304-0EE0B90A-CE0E-4B10-9DDC-2CD4E131BE0C

Q26995304-10B62A6F-E352-4CBA-82EE-712C4459F3D7

Q26995304-12D9E458-15FA-4F0B-A249-FD802DCA40D8

Q26995304-139C5573-52A7-40E3-81D8-3282559680DD

Q26995304-157C4F42-BD5D-4482-98A2-EE9F27C7A021

Q26995304-15926CDC-F13D-4EF5-A506-FD8C94B0B4E6

Q26995304-16E52B74-A77E-43F9-BD97-1258E594A8B1

P2888

Q26995304-1C38F7F6-9F8E-4569-9B66-8C0ECE6BD141

P304

Q26995304-D587ECA3-2ACA-4403-8219-3A2467AB5A57

P31

Q26995304-F26FAC64-DADC-4C1E-A058-61923721EF2E

P356

Q26995304-4A0D6C92-FF18-4D17-92C5-BB26E29ABCD3

P407

Q26995304-719ED8A2-4E40-4C16-ADBD-6C16908A8907

P433

Q26995304-65ED4338-89FA-40D4-A342-39877E02F42B

P478

Q26995304-31666CEC-AEDB-4EBC-B50A-3A22F06FA0D2

P577

Q26995304-F0482D29-70F0-4CE2-B4B1-96ED2F8EAFC3

P5875

Q26995304-5054F097-E8F3-434B-BB67-4E3A4F60E2CA

P6179

Q26995304-DCB56F69-CE5B-43EF-91A6-9D73625A27D2

P698

Q26995304-2D22702E-9338-4782-9D76-FCE38B1A7B27

P932

Q26995304-7AB98A97-17A5-46F7-A068-ED0F0B1CABBA

P356

S12248-013-9486-2

P1433

The AAPS Journal

P1476

Molecular mechanisms of silibi ...... or emphasis on prostate cancer

@en

P2093

Gagan Deep

http://www.w3.org/2001/XMLSchema#string

Harold Ting

http://www.w3.org/2001/XMLSchema#string

Rajesh Agarwal

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2012

Anti-inflammatory activity of soy and tea in prostate cancer prevention

Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells.

Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression

Flavonoids: old and new aspects of a class of natural therapeutic drugs.

Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.

Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin.

Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.

[Pharmacodynamics, site and mechanism of action of silymarin, the antihepatoxic principle from Silybum mar. (L) Gaertn. 1. Acute toxicology or tolerance, general and specific (liver-) pharmacology].

Intake of carotenoids and retinol in relation to risk of prostate cancer.

P2888

s12248-013-9486-2

P304

707-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12248-013-9486-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236185179

http://www.w3.org/2001/XMLSchema#string

P6179

1041627268

http://www.w3.org/2001/XMLSchema#string

P698

23588585

http://www.w3.org/2001/XMLSchema#string

P932

3691417

http://www.w3.org/2001/XMLSchema#string